Eswatini vs Sur: Previously treated cases tested for RR-/MDR-TB
Eswatini
100.0%
in 2024
Sur
62.0%
in 2024
Eswatini rank
1st
Sur rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Eswatini
- Sur
How they compare
Eswatini currently reports 100.0% against 62.0% in Sur, a difference of 38.0%.
That makes Eswatini's figure about 1.6 times Sur's.
The two have swapped places 4 times across 12 shared years of data; in 2008 it was Eswatini ahead.
Eswatini ranks 1st and Sur ranks 1st of 180 countries.
Eswatini has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Eswatini | Sur | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 74.0% | 43.0% | 31.0% | Eswatini |
| 2010s | 68.0% | 66.0% | 2.0% | Eswatini |
| 2020s | 100.0% | 78.4% | 21.6% | Eswatini |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Eswatini or Sur?
- Eswatini, at 100.0% against 62.0% in Sur as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Eswatini and Sur?
- 38.0%, with Eswatini ahead.
- How many years of comparable data are there for Eswatini and Sur?
- 12 years are reported by both, from 2008 to 2024.
- How do Eswatini and Sur rank globally for previously treated cases tested for rr-/mdr-tb?
- Eswatini ranks 1st and Sur ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.